Vol.58 No.S-2 October 2010
In vitro and in vivo antibacterial activity of tosufloxacin tosilate hydrate against major causative bacteria of pneumonia and otitis media in pediatric patients
Jpn. J. Chemother. 58 (S-2): 1-11, 2010
Toxicity studies of tosufloxacin tosilate hydrate in juvenile animals and class effects studies
Jpn. J. Chemother. 58 (S-2): 12-23, 2010
Pharmacokinetics and safety of oral tosufloxacin granule preparation in healthy adult subjects
Jpn. J. Chemother. 58 (S-2): 24-31, 2010
An uncontrolled, open label study of 10% tosufloxacin granules in pediatric pneumonia
Jpn. J. Chemother. 58 (S-2): 32-49, 2010
An uncontrolled, open label study of tosufloxacin granules 10% in pediatric acute otitis media (AOM)
Jpn. J. Chemother. 58 (S-2): 50-68, 2010
Population pharmacokinetics and pharmacodynamics of tosufloxacin granules in pediatric infectious diseases
Jpn. J. Chemother. 58 (S-2): 69-77, 2010
Safety profile of pediatric tosufloxacin
Jpn. J. Chemother. 58 (S-2): 78-88, 2010